<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/wp-content/plugins/squirrly-seo/view/assets/css/sitemap.xsl"?>
<!-- generated-on="2026-08-21T05:10:07+00:00" -->
<!-- generator="Squirrly SEO Sitemap" -->
<!-- generator-url="https://wordpress.org/plugins/squirrly-seo/" -->

<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:video="http://www.google.com/schemas/sitemap-video/1.1"  xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" >
	<url>
		<loc>https://vivos.com/submission-confirmation/</loc>
		<lastmod>2026-05-04T22:16:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://vivos.com/investors/press-release-detail/</loc>
		<lastmod>2026-04-08T03:00:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://vivos.com/investors/press-release/</loc>
		<lastmod>2026-04-08T02:52:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://vivos.com/thank-you-page/</loc>
		<lastmod>2026-03-31T17:35:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://vivos.com/research/</loc>
		<lastmod>2026-03-30T15:23:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://vivos.com/news/</loc>
		<lastmod>2026-03-09T21:10:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://vivos.com/nominating-and-corporate-governance-committee-charter/</loc>
		<lastmod>2026-03-05T00:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://vivos.com/compensation-charter/</loc>
		<lastmod>2026-03-05T00:49:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://vivos.com/audit-committee-charter/</loc>
		<lastmod>2026-03-05T00:48:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://vivos.com/investors/governance/whistleblower-protection-policy/</loc>
		<lastmod>2026-04-07T22:16:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://vivos.com/investors/governance/code-of-ethics/</loc>
		<lastmod>2026-04-07T22:16:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://vivos.com/investors/stock/</loc>
		<lastmod>2026-04-08T02:50:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://vivos.com/investors/governance/</loc>
		<lastmod>2026-04-07T22:15:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://vivos.com/investors/sec-filings/</loc>
		<lastmod>2026-04-08T02:49:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://vivos.com/contact/</loc>
		<lastmod>2026-03-30T20:15:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://vivos.com/about/</loc>
		<lastmod>2026-03-08T05:35:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://vivos.com/am-i-a-candidate/</loc>
		<lastmod>2026-04-01T21:52:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://vivos.com/find-a-provider/</loc>
		<lastmod>2026-04-01T21:51:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://vivos.com/investors/</loc>
		<lastmod>2026-08-14T16:09:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
		<video:video>
			<video:player_loc allow_embed="yes">https://www.youtube.com/embed/OQkO8gd_kGI</video:player_loc>
			<video:thumbnail_loc>https://img.youtube.com/vi/OQkO8gd_kGI/hqdefault.jpg</video:thumbnail_loc>
			<video:title>Investors - Vivos Therapeutics, Inc.</video:title>
			<video:description>Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call Event Details and Participant Access Call scheduled for Friday, August 14, 2026, at 5:00 pm ET. Participant Listening OptionsToll-Free: 1-800-717-1738International: 1-646-307-1865 The passcode for the replay is 1174558.</video:description>
		</video:video>
		<video:video>
			<video:player_loc allow_embed="yes">https://www.youtube.com/embed/zVE-2DFMkk4</video:player_loc>
			<video:thumbnail_loc>https://img.youtube.com/vi/zVE-2DFMkk4/hqdefault.jpg</video:thumbnail_loc>
			<video:title>Investors - Vivos Therapeutics, Inc.</video:title>
			<video:description>Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call Event Details and Participant Access Call scheduled for Friday, August 14, 2026, at 5:00 pm ET. Participant Listening OptionsToll-Free: 1-800-717-1738International: 1-646-307-1865 The passcode for the replay is 1174558.</video:description>
		</video:video>
		<video:video>
			<video:player_loc allow_embed="yes">https://www.youtube.com/embed/zFtKzS-2m2k</video:player_loc>
			<video:thumbnail_loc>https://img.youtube.com/vi/zFtKzS-2m2k/hqdefault.jpg</video:thumbnail_loc>
			<video:title>Investors - Vivos Therapeutics, Inc.</video:title>
			<video:description>Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call Event Details and Participant Access Call scheduled for Friday, August 14, 2026, at 5:00 pm ET. Participant Listening OptionsToll-Free: 1-800-717-1738International: 1-646-307-1865 The passcode for the replay is 1174558.</video:description>
		</video:video>
		<video:video>
			<video:player_loc allow_embed="yes">https://vivos.com/wp-content/uploads/2026/03/vivos-investor-page-loop-video.mp4</video:player_loc>
			<video:thumbnail_loc>https://img.youtube.com/vi/zFtKzS-2m2k/hqdefault.jpg</video:thumbnail_loc>
			<video:title>Investors - Vivos Therapeutics, Inc.</video:title>
			<video:description>Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call Event Details and Participant Access Call scheduled for Friday, August 14, 2026, at 5:00 pm ET. Participant Listening OptionsToll-Free: 1-800-717-1738International: 1-646-307-1865 The passcode for the replay is 1174558.</video:description>
		</video:video>
	</url>
	<url>
		<loc>https://vivos.com/how-it-works/</loc>
		<lastmod>2026-06-09T18:37:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
		<image:image>
			<image:loc>https://vivos.com/wp-content/uploads/2026/01/cropped-vivos-favicon-v2.webp</image:loc>
			<image:title>VIVOS Favicon</image:title>
		</image:image>
	</url>
	<url>
		<loc>https://vivos.com/childrens-health/</loc>
		<lastmod>2026-06-09T18:32:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
		<image:image>
			<image:loc>https://vivos.com/wp-content/uploads/2026/02/a-child-peacefully-sleeping-on-a-desk-in-a-classroom-with-blurred-background.-7929435-scaled.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://vivos.com/adult-solutions/</loc>
		<lastmod>2026-06-09T18:34:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
		<image:image>
			<image:loc>https://vivos.com/wp-content/uploads/2026/02/sleepy-young-brunette-female-in-white-sleepwear-resting-in-comfortable-bed-and-waking-up-with-alarm-clock-at-home-in-morning-time-7622504-scaled.jpg</image:loc>
		</image:image>
		<video:video>
			<video:player_loc allow_embed="yes">https://video.vivos.com/vivos-case-study-teri-3d.mp4</video:player_loc>
			<video:thumbnail_loc>https://vivos.com/wp-content/uploads/2026/02/sleepy-young-brunette-female-in-white-sleepwear-resting-in-comfortable-bed-and-waking-up-with-alarm-clock-at-home-in-morning-time-7622504-scaled.jpg</video:thumbnail_loc>
			<video:title>Adult Solutions - Vivos Therapeutics, Inc.</video:title>
			<video:description>Sleep Deeply. For Good. The first Oral Appliance Technology FDA-cleared to treat Severe Obstructive Sleep Apnea Obstructive sleep apnea Severe Sleep Apnea Deserves Attention If nightly mask therapy hasn’t worked, it may feel like surgery is the only alternative. Vivos is different. Our FDA-cleared oral appliance</video:description>
		</video:video>
	</url>
	<url>
		<loc>https://vivos.com/privacy-policy/</loc>
		<lastmod>2026-02-10T20:22:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>https://vivos.com</loc>
		<lastmod>2026-04-25T00:24:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.6</priority>
		<image:image>
			<image:loc>http://vivos.com/wp-content/uploads/hederson-story-testimonial.webp</image:loc>
			<image:title>Vivos Testimonials</image:title>
		</image:image>
		<video:video>
			<video:player_loc allow_embed="yes">https://vivos.com/wp-content/uploads/2026/03/vivos-sleep-apnea-permanent-solution-trailer.mp4</video:player_loc>
			<video:thumbnail_loc>http://vivos.com/wp-content/uploads/hederson-story-testimonial.webp</video:thumbnail_loc>
			<video:title>Vivos Therapeutics, Inc. - Non-Surgical Solution for Obstructive Sleep Apnea</video:title>
			<video:description>To Breathe Well is to Live Fully The only FDA-cleared oral appliance alternative to CPAP for moderate to severe OSA. No Masks. No Surgery. No Lifetime Treatment. Rethinking Sleep Apnea Treatment. Results That Last. Most patients experience significant improvement in obstructive sleep apnea symptoms. Many patients see complete resolution of their OSA.</video:description>
		</video:video>
	</url>
</urlset>
